Benign Bone Tumors: Operative Management & Surgical Techniques

Introduction to Benign Bone Tumors and Tumor-Like Lesions

The operative management of benign bone tumors and tumor-like conditions requires a profound understanding of musculoskeletal oncology, biomechanics, and advanced surgical techniques. While these lesions lack metastatic potential, their capacity for local tissue destruction, cortical expansion, and induction of pathologic fractures necessitates precise, evidence-based intervention.

Historically, the treatment of benign osseous lesions relied heavily on open en bloc resections or simple curettage, which often carried high morbidity or unacceptable recurrence rates. Over the past three decades, the paradigm has shifted toward joint-sparing, minimally invasive, and adjuvant-enhanced techniques. The integration of high-speed burring, chemical and thermal adjuvants, percutaneous sclerotherapy, and radiofrequency ablation (RFA) has revolutionized the orthopedic surgeon's armamentarium.

This masterclass delineates the surgical indications, biomechanical considerations, step-by-step operative approaches, and postoperative protocols for the most frequently encountered benign bone tumors, synthesizing decades of peer-reviewed literature into actionable surgical strategies.

Cystic Lesions of Bone

Unicameral Bone Cysts (UBC)

Unicameral bone cysts (simple bone cysts) are serous fluid-filled cavities primarily affecting the metaphyses of long bones in skeletally immature patients, most notably the proximal humerus and proximal femur.

Indications for Intervention:
* High risk of pathologic fracture (e.g., cortical thickness < 2 mm, cyst diameter > 85% of the bone cross-section).
* Active cysts abutting the physis causing growth disturbance.
* Recurrent pain or failure of conservative management.

Surgical Approaches:

1. Percutaneous Injection (Corticosteroids or Bone Marrow Aspirate):

   • Positioning: Supine on a radiolucent table. Fluoroscopy is mandatory.
   • Technique: Under image guidance, advance two large-bore Jamshidi needles into the cyst (one proximal, one distal).
   • Confirmation: Aspirate the characteristic straw-colored fluid. Perform a cystogram using radiopaque contrast to confirm continuity of the cyst and rule out loculations.
   • Injection: Flush the cyst thoroughly with normal saline to disrupt the cyst lining membrane. Inject 40 to 80 mg of methylprednisolone acetate or autologous bone marrow aspirate (harvested from the iliac crest) through one needle while venting the other.
   • Postoperative Protocol: Immediate mobilization as tolerated. Serial radiographs at 6 weeks, 3 months, and 6 months to assess consolidation.

2. Open Curettage and Bone Grafting:

   • Reserved for refractory cases or cysts with impending fractures in weight-bearing bones.
   • Technique: Create a cortical window. Perform meticulous intralesional curettage. The cavity is then packed with cancellous allograft, autograft, or synthetic bone substitutes (e.g., calcium phosphate cement) to provide immediate biomechanical stability.

Clinical Pearl: When treating a UBC complicated by a pathologic fracture, allow the fracture to heal first (usually 6–8 weeks) before addressing the cyst, as the fracture hematoma occasionally induces spontaneous cyst resolution.

Aneurysmal Bone Cysts (ABC)

Aneurysmal bone cysts are highly destructive, blood-filled, multiloculated lesions. They can be primary or secondary (arising within a giant cell tumor, chondroblastoma, or osteoblastoma).

Biomechanics and Indications:
ABCs rapidly expand the cortex, creating a "blown-out" appearance that severely compromises the bone's structural integrity. Surgical intervention is almost always indicated to prevent catastrophic mechanical failure and alleviate severe pain.

Surgical Approaches:

1. Extended Intralesional Curettage:

   • Positioning: Dependent on the anatomic site. Tourniquet use is critical for extremity lesions due to the highly vascular nature of the cyst.
   • Approach: Expose the lesion via a standard extensile approach. Create a large cortical window (unroofing the lesion) to ensure complete visualization.
   • Curettage: Evacuate the hemorrhagic, spongy tissue. Use a high-speed burr to meticulously break down all internal bony septations and extend the curettage 1–2 mm into normal reactive bone.
   • Adjuvants: The use of adjuvants is mandatory to reduce the recurrence rate from 30% to less than 10%. Options include phenol (followed by alcohol neutralization), liquid nitrogen (cryotherapy), or an argon beam coagulator.
   • Reconstruction: Pack the defect with structural allograft or polymethylmethacrylate (PMMA) bone cement. PMMA provides immediate structural support and an exothermic reaction that acts as an additional thermal adjuvant.

2. Percutaneous Sclerotherapy:

   • For surgically inaccessible lesions (e.g., pelvis, spine), percutaneous injection of sclerosing agents (such as Ethibloc or polidocanol) under CT guidance has proven highly efficacious, inducing thrombosis and subsequent ossification of the cyst.

Surgical Warning: ABCs can bleed profusely. Always ensure adequate intravenous access, have cross-matched blood available, and utilize a pneumatic tourniquet whenever anatomically feasible.

Osteoid-Producing Lesions

Osteoid Osteoma

Osteoid osteomas are benign, bone-forming tumors characterized by a highly vascularized nidus (< 1.5 cm) surrounded by dense sclerotic bone. They classically present with nocturnal pain dramatically relieved by NSAIDs.

Indications for Intervention:
* Intractable pain refractory to medical management.
* Lesions in the spine causing painful scoliosis.
* Intra-articular lesions causing synovitis or premature osteoarthritis.

Surgical Approaches:

1. Radiofrequency Ablation (RFA):

   • RFA has superseded open resection as the gold standard due to its minimal morbidity and high success rate (>90%).
   • Positioning: Patient is placed in the CT scanner. General anesthesia or deep sedation is required, as the procedure is intensely painful.
   • Technique: A biopsy needle is advanced into the exact center of the nidus under CT guidance. The RFA probe is introduced. The lesion is heated to 90°C for exactly 6 minutes, causing coagulative necrosis of the nidus.
   • Postoperative Protocol: Immediate weight-bearing. Pain relief is typically instantaneous upon waking from anesthesia.

2. Open Surgical Resection:

   • Indicated for lesions dangerously close to neurovascular structures (e.g., within 1 cm of the spinal cord) where thermal spread could cause catastrophic injury.
   • Technique: Intraoperative fluoroscopy or computer navigation is used to localize the nidus. A high-speed burr is used to unroof the sclerotic bone until the hyperemic "cherry-red" nidus is visualized and excised en bloc.

Osteoblastoma

Osteoblastomas are histologically similar to osteoid osteomas but are larger (> 2 cm), exhibit progressive growth, and do not reliably respond to NSAIDs. They have a predilection for the posterior elements of the spine.

Surgical Approach:
* Due to their aggressive local behavior, RFA is generally contraindicated.
* Technique: Extended intralesional curettage with high-speed burring or en bloc marginal resection is required. In the spine, this often necessitates concurrent spinal instrumentation and fusion due to the iatrogenic instability created by the resection of the posterior elements.

Cartilaginous Lesions

Enchondroma

Enchondromas are benign hyaline cartilage tumors located within the medullary cavity. They are the most common primary bone tumor of the hand.

Indications for Intervention:
* Symptomatic lesions (pain not attributable to other causes).
* Pathologic fracture.
* Radiographic progression or cortical scalloping suggestive of low-grade chondrosarcoma.

Surgical Approach (Hand/Phalanges):
* Positioning: Supine, arm on a hand table, finger tourniquet applied.
* Technique: A mid-lateral or dorsal approach is utilized. A precise cortical window is created using a small drill and osteotomes.
* Curettage: Meticulous curettage of the lobulated, bluish-white cartilaginous tissue is performed. A small angled curette is essential to reach under the overhanging cortical edges.
* Reconstruction: The void is filled with cancellous autograft (from the distal radius) or an injectable, in situ-curing hydroxyapatite cement. Hydroxyapatite provides excellent compressive strength, allowing for early mobilization of the digits to prevent stiffness.

Clinical Pearl: In patients with multiple enchondromatosis (Ollier disease or Maffucci syndrome), maintain a high index of suspicion for malignant transformation to secondary chondrosarcoma, which occurs in up to 30% of cases. Any sudden growth or new-onset pain warrants immediate advanced imaging and biopsy.

Osteochondroma (Exostosis)

Osteochondromas are cartilage-capped bony projections arising from the external surface of the bone, containing a marrow cavity continuous with the underlying bone.

Indications for Intervention:
* Mechanical irritation of adjacent tendons, nerves, or vessels.
* Cosmetic deformity.
* Growth after skeletal maturity (a red flag for malignant transformation to peripheral chondrosarcoma).

Surgical Approach:
* Technique: The approach is dictated by the lesion's location. The key oncologic principle is the complete excision of the cartilage cap and the overlying perichondrium.
* Execution: Dissect the overlying soft tissues bluntly. Do not violate the cartilage cap. Use an osteotome or oscillating saw to resect the stalk flush with the host bone cortex.
* Postoperative Protocol: Routine wound care and early range of motion. Recurrence is rare if the entire cartilage cap is removed.

Fibro-Osseous Lesions

Fibrous Dysplasia

Fibrous dysplasia is a developmental anomaly where normal bone and marrow are replaced by fibrous tissue and woven bone, leading to structural weakness, bowing deformities (e.g., the classic "shepherd's crook" deformity of the proximal femur), and pathologic fractures.

Biomechanics and Indications:
The woven bone in fibrous dysplasia lacks the anisotropic strength of normal lamellar bone. It is highly susceptible to shear and bending forces. Surgery is indicated for impending fractures, severe deformity, or symptomatic nonunions.

Surgical Approaches:

1. Prophylactic Internal Fixation:

   • Principle: Cortical bone grafting and rigid intramedullary fixation are the mainstays of treatment. Plates and screws are prone to pull-out failure in dysplastic bone and should be avoided.
   • Technique (Proximal Femur): A cephalomedullary nail is the implant of choice. It bypasses the dysplastic segment and transfers weight-bearing loads directly to the diaphysis.
   • Deformity Correction: If a severe shepherd's crook deformity is present, multiple closing wedge osteotomies may be required prior to nail insertion to restore the mechanical axis.

2. Cortical Strut Grafting:

   • Cancellous bone grafts are rapidly resorbed by the dysplastic process. Therefore, structural cortical allografts (e.g., fibular struts) must be used to bridge defects and provide long-term mechanical support.

Clinical Pearl: Medical optimization with intravenous bisphosphonates (e.g., pamidronate or zoledronic acid) prior to surgery significantly reduces bone pain, decreases intraoperative hemorrhage, and may slow the progression of the dysplastic tissue.

Osteofibrous Dysplasia

Often confused with fibrous dysplasia, osteofibrous dysplasia almost exclusively affects the anterior cortex of the tibia in children, presenting as anterolateral bowing.

Surgical Approach:
* Observation is the first line of treatment, as many lesions stabilize or regress after skeletal maturity.
* If surgical intervention is required for severe deformity or fracture, marginal en bloc resection is preferred over curettage, as curettage carries a high recurrence rate.
* Warning: Osteofibrous dysplasia shares a complex histopathologic relationship with adamantinoma (a low-grade malignant tumor). An extensive incisional biopsy is mandatory prior to any definitive fixation to rule out adamantinoma.

Postoperative Rehabilitation and Surveillance

The postoperative protocol for benign bone tumors is dictated by the size of the defect, the anatomic location, and the method of reconstruction.

1. Weight-Bearing Status:

   • Upper Extremity: Immediate active range of motion is encouraged to prevent adhesive capsulitis or tendon adhesions, particularly following hand surgery for enchondromas.
   • Lower Extremity: If the cortical defect exceeds 30% of the bone diameter, protective weight-bearing (touch-down or partial) with crutches is mandatory for 6 to 12 weeks until radiographic evidence of graft incorporation or cement stabilization is confirmed.

2. Radiographic Surveillance:

   • Baseline orthogonal radiographs should be obtained in the Post-Anesthesia Care Unit (PACU).
   • Follow-up imaging is typically scheduled at 2 weeks, 6 weeks, 3 months, 6 months, and annually thereafter for a minimum of two years.
   • MRI is reserved for cases of suspected recurrence, particularly in aggressive lesions like ABCs or giant cell tumors.

Conclusion

The operative management of benign bone tumors demands a meticulous, pathology-specific approach. The modern orthopedic surgeon must balance the oncologic principles of complete lesion eradication with the biomechanical imperatives of joint preservation and structural stability. Through the judicious application of extended curettage, thermal ablation, and rigid intramedullary reconstruction, surgeons can achieve excellent functional outcomes, minimize recurrence, and safely restore patients to their pre-morbid activity levels.